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Background: Few studies describe system-level challenges or facilitators to implementing population-based
colorectal cancer (CRC) screening outreach programs. Our qualitative study explored viewpoints of multilevel
stakeholders before, during, and after implementation of a centralized outreach program. Program implementation
was part of a broader quality-improvement initiative.
Methods: During 2008–2010, we conducted semi-structured, open-ended individual interviews and focus groups at
Kaiser Permanente Northwest (KPNW), a not-for-profit group model health maintenance organization using the
practical robust implementation and sustainability model to explore external and internal barriers to CRC screening.
We interviewed 55 stakeholders: 8 health plan leaders, 20 primary care providers, 4 program managers, and 23
endoscopy specialists (15 gastroenterologists, 8 general surgeons), and analyzed interview transcripts to identify
common as well as divergent opinions expressed by stakeholders.
Results: The majority of stakeholders at various levels consistently reported that an automated telephone-reminder
system to contact patients and coordinate mailing fecal tests alleviated organizational constraints on staff’s time
and resources. Changing to a single-sample fecal immunochemical test (FIT) lessened patient and provider concerns
about feasibility and accuracy of fecal testing. The centralized telephonic outreach program did, however, result in
some screening duplication and overuse. Higher rates of FIT completion and a higher proportion of positive results
with FIT required more colonoscopies.
Conclusions: Addressing barriers at multiple levels of a health system by changing the delivery system design
to add a centralized outreach program, switching to a more accurate and easier-to-use fecal test, and providing
educational and electronic support had both benefits and problematic consequences. Other health care organizations
can use our results to understand the complexities of implementing centralized screening programs.
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Colorectal cancer (CRC) is the third most common non-
skin cancer, and the second leading cause of cancer-
related death, in the U.S. [1]. The early detection of
high-risk lesions or of CRC itself through appropriate
screening is associated with decreased incidence of and
mortality from CRC [2-4]. Currently, recommended
CRC screening modalities for average-risk patients in-
clude annual fecal occult blood testing (FOBT) or colon-
oscopy every 10 years, or flexible sigmoidoscopy every
5 years, with or without interval FOBT [5]. In addition,
as a result of improved test performance and usability,
in 2008, multiple professional societies endorsed the use
of four types of fecal immunochemical tests (FIT) to re-
place guaiac FOBT for CRC screening [6].
Despite the proven benefits, CRC screening at regular
intervals for age-appropriate populations remains sub-
optimal in the U.S.. Although more than half of adults
aged 50 and older in the U.S. have ever received a CRC
screening test, millions of Americans are not receiving
CRC screening at all, or are not repeating screening tests
at recommended intervals [7]. Population-based screen-
ing programs that employ patient-screening reminders
[8-11], provision of stool tests to complete at home [12],
and provider feedback are effective for improving uptake
of CRC screening [13]. Prior studies in systems in the U.
S. that offer more than one type of screening test
(i.e., both endoscopy and fecal testing) demonstrate that
one-to-one counseling of patients by nurses, patient nav-
igators, or health educators also modestly increase
screening rates [4,14,15]. However, there are few studies
[15] on system-level challenges, or on determinants of
success, encountered in the process of implementing
such programs.
We conducted a qualitative case study [16-18] to ex-
plore the viewpoints of multilevel stakeholders imple-
menting a centralized population-based CRC screening
program and quality-improvement initiative in an inte-
grated health system in the U.S. between 2009 and 2011.
At the study site, screening flexible sigmoidoscopy and
guaiac-based FOBT were available as screening options
until 2008, when the health system began offering an
additional option of screening colonoscopy. Within the
system, the primary care provider provides an electronic
fecal test order (a process termed “in-reach”) or a refer-
ral to specialty care for flexible sigmoidoscopy or colon-
oscopy when seeing the patient in a clinic visit. Our
previously published randomized trial [19] (Clinical-
Trials.gov identifier: NCT00656838) comparing an auto-
mated telephone contact campaign encouraging fecal
test screening to clinic-based encouragement of fecal
testing (usual care) found that those in the intervention
group were significantly more likely to complete a fecal
test (hazard ratio, 1.31; 95% confidence interval, 1.10–1.56) compared with usual care. In 2008, the health sys-
tem implemented this automated telephone contact
campaign and in 2009, enabling a centralized order for a
fecal test (a process termed “outreach”) and direct mail-
ing of the kits to interested patients. The health system
also implemented several related quality initiatives sup-
porting colorectal cancer screening and switched from
guaiac fecal occult blood testing to fecal immunochemi-
cal testing (FIT) around the same time. Our study used
a combination of semi-structured, open-ended individual
interviews and focus groups. We aimed to provide suffi-
cient in-depth description from stakeholder groups to
generate breadth and depth of information, and to
maximize trustworthiness and credibility of data [20,21].
We also investigated specific barriers and facilitators of
colorectal cancer screening from stakeholder perspec-
tives at different levels within the organization, and ex-
plored unintended consequences of the program.Methods
Study site and data systems
We conducted our qualitative study between 2008 and
2010 at Kaiser Permanente Northwest (KPNW), a not-
for-profit group model health maintenance organization
(HMO) with about 485,000 members in Southern Wash-
ington and the Portland, Oregon, metro area. KPNW re-
gional electronic databases capture >95% of all medical
care and pharmacy services members receive, and data
are linked through each member’s health record number.
A full electronic medical record (EMR) has been in place
since 1996. The study design and procedures were ap-
proved by KPNW’s institutional review board, and inter-
view participants provided written informed consent.CRC phone-reminder program and surrounding quality-
improvement activities
Our qualitative study was designed to take advantage of
an already in-process change in care practices at KPNW. In
2008, the organization implemented a new CRC screening-
reminder program and related quality-improvement initia-
tives. The reminder program used automated phone
calls to encourage CRC screening for average-risk, age-
appropriate members who were coming due, all identified
through diagnosis and procedural codes in the electronic
medical record. Details on the design and outcomes of this
program are reported elsewhere [19]. Briefly, the automated
reminder call was about 1 min in length and provided an
overview of the benefits of CRC screening. Recipients could
request fecal test kits by pressing a number via touch-tone
telephone. The automated system had an algorithm for
accepting calls back, leaving messages, and for reminding
those who had already received a kit in the mail to
complete it.
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included heightened training of providers (through in-
person education, decision support tools in the EMR,
and evidence-based practice guidelines) highlighting CRC
screening importance and methods. The organization
also implemented staff financial incentives for meeting
organizational target goals in CRC screening rates.Conceptual framework for evaluating local practices in a
larger context
The guiding framework for our study was the practical
robust implementation and sustainability model (PRISM
[22], presented in Figure 1). PRISM advocates for docu-
menting and defining key factors or “leverage points” at
multiple levels of internal and external stakeholder
influence. The model considers how the external environ-
ment, intervention design, implementation infrastructure,
and adopting organization (with particular emphasis on the
health care teams and providers) and its patients influence
program implementation and success. PRISM expands
upon the RE-AIM framework [23,24], derived from work in
the diffusion of innovations [25-27], and is supported by so-
cial ecology and the PRECEDE/PROCEED model [23,28].
The adaptation of PRISM for this study is illustrated in
Figure 2.Figure 1 The practical robust implementation and sustainability m
into practice considers how the program or intervention design, the ex
infrastructure, and the recipients (especially at the level of health care p
implementation, and maintenance.Study participants and recruitment
We gathered qualitative data from 55 participants from
different levels of the organization: 8 health plan leaders,
4 program managers, 23 endoscopy specialists (15 gas-
troenterologists, 8 general surgeons), and 20 primary
care providers (PCPs).
We identified health plan leaders and managers based
on their role in the organization as a resource and pro-
gram decision-maker, and/or their role in designing and
implementing the CRC screening program. We invited
all health plan leaders through an organizational e-mail
to participate in a 45-min face-to-face interview, and
provided lunch for participants. All of them agreed to
participate. We interviewed four of them prior to the
intervention and four of them after the intervention, to
obtain perspectives over time on the anticipated and re-
alized successes and challenges of the implementation.
We also invited four managers designing and imple-
menting the centralized CRC screening program (n = 4)
to a 90-min focus group, occurring after the interven-
tion; all of them participated.
We identified gastroenterologists and general surgeons
because they conduct CRC screening endoscopy (colonos-
copy and flexible sigmoidoscopy) within the organization.
We obtained permission to conduct a 30-min focus group
with the gastroenterologists during a regional staff meeting;odel (PRISM). The PRISM model for integrating research findings
ternal environment, the implementation and sustainability
roviders and their support staff) influence program adoption,
Intervention Design:
1. Centralized telephone campaign
2. Change from FOBT to FIT





















Figure 2 A qualitative study of stakeholder assessment of a colorectal cancer screening program by PRISM domains. This adapted
PRISM diagram outlines how stakeholder interviews among both the initiators and recipients of a multimodal program of colorectal cancer
screening evaluated the screening program. It shows the relative roles of the stakeholder groups as initiators (leadership and management)
and/or recipients (specialists, primary care providers, leaders, and managers) of the intervention. Stakeholders reflected upon the historical barriers
and facilitators to colorectal cancer screening, considering characteristics of the organization itself, external environment and implementation
infrastructure of the organization. They also gave input into the successes of the intervention and described remaining challenges, in relation to
the organizational characteristics.
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pation in the focus group was optional (with informed
consent obtained). All 15 gastroenterologists present
at the meeting participated. We conducted a similar
but separate focus group for the general surgeons; 8
out of 11 general surgeons present actively partici-
pated, while 3 listened but did not share in the discus-
sion. These focus groups occurred toward the end of
the intervention phase.
We identified and interviewed 20 PCPs [20,29,30] who
had different practice emphases on CRC screening test
type and varying overall screening rates. We generated a
list of family practice (FP) and internal medicine (IM)
providers who had adult patient panels in 2008 (n = 250)
with at least 20 patients eligible for CRC screening
(n = 246). We identified “lower” (<20th percentile) and
“higher” (>80th percentile) performers based upon
their 2008 CRC screening-performance rates ascertained
through routine HEDIS quality measures by the health
plan. We further divided the list into those who used
more stool tests and those who used more endoscopy,
based on proportion of completed tests. From this
process, we identified a total of 102 PCPs and sent out
67 individual recruitment emails to a representative
subgroup of the identified list to reach a total of 20; both
PCPs and the staff recruiting and conducting the
interviews were blinded to whether they fell into the
“lower” or “higher” screening performance groups. Forty-one participants provided no response to the email invita-
tion, and 6 participants indicated scheduling conflicts or
lack of time as their reason for not participating.
Data collection and analysis
A trained, third-party qualitative methodologist not
known to the participants [JS] conducted interviews, and
interviews were audio-recorded and professionally tran-
scribed for analysis. Focus groups were facilitated by
both EL and JS, with notes taken manually by JS. Inter-
view and focus group questions elicited information
about stakeholders’ perspectives regarding barriers and
facilitators to CRC screening in general, and specifically
within the organization; overall reaction to the organiza-
tion’s CRC screening program, including to the use of
automatic reminder calls and stool tests. Questions also
elicited advice on improving the CRC screening pro-
gram. The research team developed and refined inter-
view and focus group guides using an iterative approach,
whereby team members regularly met to discuss themes
generated by prior interviews and to consider areas of
exploration for subsequent interviews [30-32]. Coauthor
JS led the analyses, with guidance and input from the re-
search team. We used a content analysis approach, aided
by the use of a qualitative-research software package,
ATLAS.ti 5.0 (Scientific Software Development, 1997)
to code data and generate reports of coded text for ana-
lysis. We developed a coding dictionary based on the
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Transcribed interviews were coded by marking passages of
text with phrases indicating content of the discussions.
Using the report and query functions of ATLAS.ti, we
reviewed coded text through a deductive process, resulting
in refined themes [29,33,34].Results and discussion
Historical barriers to CRC screening
Unclear screening test emphasis
The most commonly perceived external (non-organizational)
barrier expressed was that expert opinions about the
best screening option for low- or average-risk patients
were inconsistent. Internal CRC screening recommen-
dations had changed over the course of 5 years, with
an emphasis on sigmoidoscopy initially, followed by an
emphasis on stool testing, followed by allowance of
multiple options. Health plan leaders/managers stated
that there were too many screening options in the
system (i.e., flexible sigmoidoscopy, colonoscopy, and
fecal testing), with limited guidance for providers and
patients about which test to choose. Specialists and
health plan leaders/managers alike perceived that
PCPs, influenced by training or work culture, may pro-
mote primarily screening colonoscopies rather than
stool tests or sigmoidoscopy as options for average/
low-risk patients. Similarly, PCPs and some of the spe-
cialists expressed discomfort with the previous years’
focus on stool tests and flexible sigmoidoscopy as
preferred screening options, rather than colonoscopy,
because this emphasis did not match community
norms and expectations. Primary care providers
expressed that they received a “mixed-message” from
the organization by being allowed to refer patients to colon-
oscopy to screen for CRC in average-risk patients, but then
were not always supported by health plan leaders or spe-
cialists for doing so. They also said that frequent changes in
the emphasis on screening options for patients created con-
fusing expectations (Table 1).Colonoscopy resource constraints
Stakeholders also uniformly expressed concern about
limited availability of trained specialists for conducting
screening colonoscopies. Surgery and gastroenterology
specialists said that inappropriate referrals for colonos-
copy further strained already limited colonoscopy re-
sources. Primary care providers reported that resource
constraints created challenges with patient rapport, due
to having to explain and negotiate the long wait for ac-
cess to a screening colonoscopy. They described as chal-
lenging working in an environment that had undergone
numerous shifts in how the organization allocated CRC
screening resources.Primary care and specialty department constraints
PCPs felt specialists lacked appreciation or awareness of
the time constraints and pressures they are under during
a 20-min office visit, making it challenging to always
thoroughly discuss with patients CRC screening import-
ance, risk/benefits, and various screening options. The
challenge of offering patients a choice in the discussion
of CRC screening options compounded the problem.
PCPs felt a lack of support in ensuring that patients
followed through with screening completion. They felt
the communication from support staff to patients about
how to return completed stool test kits was inconsistent
and confusing. Additionally, PCPs felt the referral process
for a screening colonoscopy involved too many steps and
departments, leaving room for miscommunication, misun-
derstanding, and lack of follow-up with the patient. Special-
ists acknowledged that they had historically tended to have
a limited role in shaping the organizations CRC screening
program.
Historical facilitators to CRC screening
Historical emphasis on prevention
Health plan leaders and managers described a historical
focus on quality and prevention in the organization’s
mission as a facilitator of continued efforts to improve
CRC screening rates. They were spurred on by the fact
that the local organization’s quality performance num-
bers for CRC screening had historically been lower than
those in other regions, who had demonstrated improve-
ment by adopting a more formalized and centralized
outreach program. They also reported prior successes in
improving screening rates for other prevention measures
(e.g., mammography screening) through a centralized re-
minder program as a strong motivator to continue to
innovate. Health plan leaders cited this example as inspir-
ation that a sustainable and cost-effective population-based
CRC screening program acceptable to both providers and
patients was possible (Table 2).
Preexisting integrated structure for dissemination of key
practices
Health plan leaders cited their confidence in the abilities
of key leaders, managers, and implementation groups
within the integrated health system. PCPs emphasized
the importance of experts in the system to facilitate
CRC screening knowledge and programs. They also cited
a strong trust in the skill level, training, and recommen-
dations of endoscopy specialists in the organization.
They also valued having a PCP champion within the
system who could help colleagues both navigate and in-
tegrate new CRC research with organizational goals and
patient preferences. Some PCPs also found that the
EMR tools that alert them when CRC screening is due,
or show indications of prior completed screenings, were
Table 1 Historical barriers to CRC screening (n = 55)
Summary of individual themes related to organizational challenges Sample of illustrative quotes (stakeholder group identified)
Unclear evidence on choosing screening tests
Too many options in the system for screening and no clear guidelines
for providers or patients
“It’s amazing the paucity of evidence around what’s really the best
test. The stool cards have been tested more rigorously than other
interventions, so we know more about that. But that doesn’t necessarily
mean we know that colonoscopy is not as good.” —HP leader
Mixed-message received from health plan because of allowing referral
for screening colonoscopies, but not having full support to get the
colonoscopies done
“Initially, there was tremendous resistance to doing colonoscopies on
people that didn’t have a first degree relative with a history of colon
cancer. And, we were under-utilizing the hemoccults. But we would get
into a twenty minute debate with a patient who wanted a colonoscopy…
So, I never know what’s right or whether our system just had it’s resources
in the wrong place. First they tell you to do one thing in the system, then
it changes… it makes you dizzy.” —PCP
Prior organizational focus on fecal tests and flexible sigmoidoscopy
not matching community standard or national recommendations
“The community standard for screening is colonoscopy as recommended
by the American Society of Gastroenterologists… Then [patients] say,
‘Well, the Internet’s kind of said that that’s really the best thing to do.’
And then we have to say, ‘Well, we’re not offering that to you.’ And that
can be quite contradictory. And having that conversation can be quite
challenging.”—General surgeon
PCPs and specialists influenced by training or culture promote only
screening colonoscopy and not other options (e.g., fecal test) for
low-risk patients
“A lot of the younger primary care docs… were influenced by… one of
the leaders in the field… [The] one lecture a year he gave to the house
staff was that colonoscopy is the way to go.”—GI specialist
Colonoscopy resource constraints
Restricted access to screening colonoscopy within the organization “How tight the access issue is, is an ongoing sort of challenge and
frustration for the GI department.” —GI specialist
PCPs ordering screening colonoscopies when the patient is symptomatic,
rather than as a diagnostic test, complicates triaging a limited resource
“I think our system would benefit if we actually went back to basics… It
seems like we get a lot of referrals for screening when the patient has
abdominal bloating or they have diarrhea. It’s not clear if the other person
on the other end understands what the term screening really means…
That really blurs the triaging to try to figure out which patients to see first
and get things done effectively.”—GI specialist
Over-screening the already screened or offering screening to those
who may not need it (e.g., patient on hospice care) complicates
triaging a limited resource
“People with a life expectancy of less than five years, it makes absolutely
no sense to offer them colon cancer screening, but we see this all the
time. Or if they have Class 4 heart failure, or if they have some other
cancer that has failed chemotherapy and they’re on hospice.”—GI specialist
Primary care and specialty department constraints
Lack of time during office visit and addressing patients’ competing
demands makes thoroughly discussing CRC screening and options
difficult
“I find it hard when someone is in for something else and these [CRC
screening] orders get pended, that I don’t feel like talking about in that
visit because they’ve just been diagnosed with diabetes or there’s
something really pressing going on that I need to talk about with the
patient… it’s not the time to talk about colon cancer screening.” —PCP
Hard to negotiate both patient demand and offer “choice” of test
while also honoring organizational emphasis on fecal testing
“As a clinician here, since we aren’t pushing or embracing the idea of
colonoscopy as primary screening, the conversations I end up having to
have with patients who want colonoscopy [involve] talking about a long
wait time in getting them a colonoscopy if they want it, even though it’s
not our first recommendation.” —PCP
Referral process for a screening colonoscopy involves multiple steps
and departments, which sometimes creates miscommunication and
lack of follow-up
“The referral is more challenging than for something like a Pap, which I can
do it when they come in. I have more control over that. As opposed to CRC
screening [colonoscopy] and having to send in a referral, having the patient
be called back or a letter sent. It’s just more steps to get in.” —PCP
Specialists tend to have a limited historical role in helping to shape
organization’s CRC screening approach
“The (surgery) department hasn’t really provided any leadership around
influencing colon cancer screening. They’ve played a passive role, for the
most part, in supporting what was the flex sig [sic] program as an orphan
department. I don’t recollect surgeons being on the colon cancer
screening meetings for the last number of years.” —General surgeon
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ported that use of support staff (medical assistants)
trained in educating and motivating patients on screen-
ing and follow-up helped them to screen more patients.Recent emphasis on increasing access to colonoscopy
Specialists identified the importance of increasing future ac-
cess to colonoscopy and discussed solutions such as having
general surgeons and other staff trained in conducting
Table 2 Historical facilitators to CRC screening (n = 55)
Summary of themes related to organizational facilitators Sample of illustrative quotes (stakeholder group identified)
Organization’s historical emphasis on prevention
Overall focus on quality and prevention as a primary part of
organization’s mission and values
“The one thing we don’t argue is that we need screening of some type
for colon cancer. Everyone knows the old adage is that any screen is
better than no screening. So we all agree that we need to get there to
screen the population. And we’ve got to decide what’s the best way to
do it for our population.” —GI specialist
Internal success at raising screening rates for other health issues
(e.g., mammography for breast cancer screening) using a centralized
outreach reminder approach
“Clearly, we had great results with breast cancer screening, and we had
some good results with cervical cancer too… So that was part of what
we wanted to test, does IVR calling work as well [for CRC]?” —HP leader
Quality performance numbers for CRC screening were not as good as
other comparable health care organizations
“We saw what our screening rates were… and we looked around at
other regions to see what they were doing successfully. Mid-Atlantic
had used [interactive voice recognition]. And so I worked really closely
with Mid-Atlantic to find out which IVR they used and what their success
rate was with CRC screening… ” —HP leader
Preexisting integrated structure for dissemination of key practices
Trust in the structure of the integrated health system to enable
alignment of evidence-based CRC screening approaches with
available resources and department roles
“And I know that, you know, we had a very strong analyst. We had a very
strong negotiator. We had a strong physician lead who was very
interested and extremely engaged. And then we had a project manager,
I mean, that could just kind of manage all the pieces and make sure that
everybody shows up and things are done in a timeline.” —HP leader
Strong trust in the skill level, training, and recommendations of
endoscopy specialists
“I think that the GI doctors are just so dang ethical and skilled… they’re not
going to recommend something just to save the organization money, and
they’re still going to have the patient’s best interest in mind.” —PCP
Use of support staff (medical assistants) trained in educating and
motivating patients on screening and follow-up
“We have our own MAs and own staff and we can say, okay, when a
patient checks in and they’re due for one of these, you hand them this. If
there’s no need, not involving the physician just speeds up things. If you
have a nice handout and your staff is knowledgeable about the task and
can explain it to somebody, like an MA, there’s no reason for taking time
out of an appointment for the physician to go over the test, when the
patient is there for something else. So finding the earliest person who is
able to deliver the message early on is better.” —HP leader
Presence of PCP champions to assist other providers in navigating and
integrating latest research with organizational goals and patient demand
“Presentations and talks [with clinician champion] have really been
helpful. They have helped me kind of frame my conversations about
everything… having a clinician who has looked at the research is really
powerful.” —PCP
Access and utilization to EMR tools that help identify screening gap or
indicate prior completed screening. Recent emphasis on increasing
access to colonoscopy
“Systematically we are pretty good at reaching out to people and [we]
have pretty good tools to identify them. We know who they are. We
know what they need. And, we have a pretty good process to tell them
what they need and to try to connect the dots for them.” —HP leader
Recent emphasis on increasing access to colonoscopy
General surgeons and other staff trained in colonoscopies alleviated
some resource/access constraints
“Fortunately, the backlog in GI is down quite a bit from what it used to
be. When I first got here, it was a two year wait, and now it’s maybe
three months. So it’s totally manageable since they have obtained
enough manpower to actually do the testing, which is great.” —PCP
Organizational shift allowed more flexibility and support for referring
patients’ to a screening colonoscopy, especially if patient requested
“Now I can refer them to colonoscopy. And with the FIT I can have
these easier conversations. So I’m promoting FIT, but if they still want
the colonoscopy, I’m going to refer for it.” —HP leader/PCP
Overall improvement in organizational CRC guidelines to make them
more in line with national standards and emphasis on colonoscopy
“Until recently, the organizational recommendation was hemoccult
testing and flex sig [sic]. And, that probably was not the community
standard or the national standard… More recently, the GI Department
has made colonoscopy more available. And I think that’s been a real
advantage in my patient population and getting them screened.” —PCP
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support the program’s efforts because they see first-
hand the consequences of colon cancer for patients.
PCPs perceived a subtle organizational shift in recent
years that had allowed them to more easily refer pa-
tients for screening colonoscopies, particularly if thatwas the patient’s preference. This, along with decreas-
ing the wait time for screening colonoscopies, and
adjusting the organization’s CRC guidelines to be more
in line with the U.S. emphasis on colonoscopy, were
also perceived by PCPs as important organizational
changes that facilitated CRC screening.
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Automated telephonic outreach successes and challenges
Health plan leaders felt the reminder calls had helped to
improve the organization’s CRC screening rates, and said
that calls are an effective, sustainable resource for sup-
porting the organization’s efforts to screen a large popu-
lation. They described the reminder calls as acceptable
to patients, patient-centered, friendly, and easy to follow.
PCPs said the reminder program helped to decrease
workload for providers and health care teams by de-
creasing the need for individual providers to conduct
their own outreach. Challenges to successful implemen-
tation of the centralized, automated reminder program
identified by health plan leaders and managers centered
on the interface of the program with the electronic
medical record, with Medicare and Medicaid regula-
tions, and with population health services sending kits
to patients. They recommended involving the informa-
tion technology (IT) department early in order to opti-
mally integrate automated calls with the EMR. Health
plan managers identified the challenge of being ad-
equately staffed to quickly enter orders in the EMR
and get them mailed to patients who wanted a stool
test. This constraint initially decreased interest and
compliance in completing or returning the stool test
kits. They recommended streamlining the ordering of
the stool test for patients due to receive a reminder
call so the order would already be in the EMR, ready
to be acted upon. They also suggested automatically
sending stool test kits to every person who is due for
screening following the receipt of a reminder call
(Tables 3 and 4a, b).Fecal immunochemical tests
Health plan managers felt that implementation of FIT
increased patient compliance with the stool test
method of screening; instructions for completing FIT
were perceived as being easier for patients to follow.
Yet, both health plan leaders and PCPs felt there was
room for improving the readability of instructions and
protocols for distribution of kits; for example, some
kits distributed in clinic were returning to the lab
without proper patient identification labels. Health
plan leaders felt that the transition to FIT further in-
creased the organization’s CRC screening rate from
prior years. PCPs and health plan managers described
how ease of FIT completion made discussion about
CRC screening easier and more efficient. Additionally,
PCPs said that increased test sensitivity of FIT has
raised their enthusiasm for, and trust in, stool test
screening. Specialists expressed enthusiasm about hav-
ing a centralized screening program, but also ambivalence
about prioritizing fecal testing over colonoscopy.Communication about organizational screening approach
All three stakeholder groups felt the organization had
improved its communication so to provide a unified
message to providers to encourage and discuss FIT
screening as an option, and offer screening colonoscopy
if the patient preferred this option. Nonetheless, all
stakeholder groups felt there were still some providers
who believed that colonoscopy is the only acceptable
method for CRC screening for average-risk patients.
Health plan leaders and PCPs both felt the organization
continues to lack effective and clear methods to commu-
nicate the organization’s CRC screening approach to all
providers. Specialists said there was a need for commu-
nication to help staff see the screening program as an in-
tegrated service involving input and effort from multiple
departments such as surgery, gastroenterology, primary
care, and oncology. PCPs and health plan leaders identi-
fied the helpfulness of education on resource steward-
ship and on feedback of providers’ screening tendencies.
Yet, health plan leaders expressed the desire for more ef-
fective ways to communicate and educate providers
about resource stewardship issues and evidence-based
outcomes as they pertain to CRC screening.
Concern about screening duplication
There was concern from all three stakeholder groups
that the current CRC program may be creating some
screening duplication, contributing to inefficient use of
resources. Health plan leaders endorsed the multimodal
approach to offering screening options to patients (i.e.,
at patient visits (in-reach) and via automated calls (out-
reach) as important attributes of improved screening
rates. Yet, health plan leaders and PCPs identified that
the lack of integration or documentation of the reminder
calls in the EMR created challenges by increasing pro-
viders’ chances of duplication of effort or service. PCPs
desired clearer prompting through the EMR about
patient screening status (in particular, whether they had
received an automated call) during the clinic visit. Spe-
cialists felt strongly that improving EMR alerts and di-
rections for providers/support staff could also prevent
patients who had a recent normal colonoscopy from
receiving a FIT. PCPs and specialists found overall docu-
mentation of prior colonoscopy results to be inconsist-
ent and confusing, as they could not always discern what
were recommended next steps for future screening.
Specialists were frustrated that some patients were still
inappropriately screened, such as the very elderly or hos-
pice patients. Concern about screening duplication gen-
erated questions where evidence-based practices and
policies were unclear. For example, specialists and health
plan leaders described a lack of clarity on protocols for
patients with a negative FIT who requested a screening
colonoscopy within the same year.
Table 3 Lessons learned: implementation successes (n = 55)






Sample of illustrative quotes (stakeholder group
identified)
Use of automated telephone outreach
Helped to improve screening rates from previous years ✓ “I think the work that we’re doing in outreach with
those modalities has been the reason we have
significantly increased our screening rate… I think
we’ve gone up six or seven percent in the last
year.” —HP leader
An effective and resource sustainable method for increasing
and maintaining CRC screening in a large population
✓ “I think it’s the way to address all kinds of things. And
we’ve done it in a number of other areas… I think you
want to have a centralized approach.” —HP leader
Patient-centered, friendly, easy to follow and use ✓ “It was amazing… we were able to keep members
on the phone for up to five minutes because it was so
interactive.” —HP leader
Decreased workload burden for providers/health care
teams for conducting outreach calls for screening
✓ ✓ “For colon cancer screening, what we pretty much
have always done is in-reach during a visit… having an
automated program makes it easier for us—especially
for reaching those people whom we never see [in a
visit] and tend to miss.” —PCP
Made PCP/health care team discussions with patients about
CRC screening easier by reinforcing awareness and
knowledge of importance of screening
✓ ✓ “Ironically, lately I’ve been finding a lot of patients
who, when I say, ‘Well, now we need to do that
poop test.’ They’ll say, ‘Oh, I just turned that in.’
[Laughs] They’ve already done it… So it [a reminder
program] just makes those conversations about
screening easier.” —PCP
Use of fecal immunochemical tests
Transition to FIT further increased the organization’s. CRC
screening rate from prior years/increased patient
compliance with the fecal test method of screening
✓ ✓ ✓ “And it’s just remarkable how many more of them are
getting done. Now, part of that is that you only have to
do one. You don’t have to do three. You don’t have to
worry about the diet, like you did with the FOBT. So, it’s
a lot easier, I think.” —HP leader
Adoption of FIT has given providers a fecal test method
they have greater trust in and enthusiasm for due to
increased patient compliance and test sensitivity
✓ ✓ ✓ “From a population perspective, it is the most effective
because people will do it. And it’s easy, and it’s efficient.
And it has literature to support it. So, it’s got all the
right stuff.” —HP leader
Removed common barriers to fecal test completion for
patients and made motivation/discussion about. CRC
screening easier and more efficient
✓ ✓ “But I think now, with the FIT test, it’s so much easier
to have the conversation and just explain it’s
different and really easy to use. How you collect your
sample and how you send it out is so much easier.
You don’t have to change your diet. So I think that
has improved.” —HP leader
Communication about organizational screening approach
Improved ability to provide a more unified message to all
providers to encourage/discuss FIT for average-risk patients
first, followed by offering colonoscopy if patient prefers or
demands
✓ ✓ ✓ “It’s clear a lot of time and effort has been invested
in communicating to Kaiser clinicians to see
colonoscopy as not a better test than these other
tools, and to offer stool card testing. I’ve probably
been brought around to that line of thinking… I
certainly think the newer stool card testing [FIT]
has more merit… so it’s been a little bit easier for
me to make my peace with that.” —PCP
Provides confidence in automated reminders, yearly FIT
cards, and ongoing ability to offer screening colonoscopy
✓ ✓ ✓ “It’s a wonderful thing that we finally have turned on a
screening program.” —GI specialist
Fewer organizational barriers to CRC screening than before
implementation efforts
✓ ✓ “Things are moving in a positive direction. I don’t see a
whole lot of challenges necessarily, compared with a
couple of years ago… I really think the barriers have
been reduced. I think there’s been more provider
satisfaction, and patient satisfaction as a result of those
activities.” —PCP
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Table 3 Lessons learned: implementation successes (n = 55) (Continued)
Education and communication about resource stewardship
and evidence based outcomes as it pertains to CRC
screening seen as helpful
✓ ✓ “Just recently, we’ve actually fed back to physicians,
what their colonoscopy rate was versus their
colleague who has the same risk adjusted
population. And, some doctors were just mortified
that they were sending out twenty times more than
the doctor down the hall who had patients that
weren’t that different… so as an organization, we
owe all of our patients a research stewardship
perspective.” —HP leader
Check symbol indicates theme brought up by more than half the stakeholder group.
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PCPs and health plan leaders both underlined the need
to improve patient education regarding CRC screening
importance and options. PCPs requested more consist-
ent educational tools to help patients navigate screening
information and options (e.g., visual aids for discussion,
exam-room posters, and patient handouts). Specialists
emphasized the need to proactively educate patients
about all available CRC screening choices. PCPs and
health plan leaders agreed on the need to increase and
standardize training of support staff in order to expand
staff roles in CRC screening, since support staff are often
the ones who see patients first and place the screening
order in the system; they suggested enabling preordering
of the screening test during rooming procedures.
The need to increase staff and colonoscopy resources
and access
The greatest challenge to implementing FIT, as identified
by health plan leaders and specialists, was unintention-
ally creating resource and access issues with colonoscopy
services due to the increased compliance with, and sen-
sitivity of, the test. Health plan leaders and PCPs felt that
there is still a need for additional highly trained staff to
provide endoscopy services, including colonoscopies.
PCPs advocated for the organization to train more mid-
level providers to conduct colonoscopies to assist with
issues of access. Specialists emphasized their desire for
patients to be able to self-refer for CRC screening, simi-
lar to the breast cancer screening program already in
place. Self-referral would allow the patient to choose any
of the tests available and have direct access to schedul-
ing, rather than requesting a referral from a primary care
provider. At the time of this publication, the health sys-
tem does not offer self-referral for endoscopy.
Discussion
Prior studies have evaluated implementation of colo-
rectal cancer screening programs within medically
underserved populations in the U.S. [35-37], whereas
this study specifically focuses on the effects of an in-
novative quality-improvement program to improve
screening rates among members of an integrated
health plan that serves mostly insured individuals. Themultimodal quality-improvement approach was aligned
with the PRISM framework, [22] which emphasizes im-
plementation of multiple changes at once (or serially)
while specifically taking into account the strengths and
needs of the delivery system; Table 5 summarizes the
facilitators and barriers to implementation of the pro-
gram, for each of the PRISM domains. A key aspect of
the program was a centralized automated telephone
calling campaign, which we demonstrated previously
to independently increase screening rates about 6.5%
[19]. During the 2 years of implementation of the
entire quality-improvement program, from 2008 to
2010, colorectal cancer screening rates increased from
54.8% to 65.9%. They have continued to rise, and in
2013 reached 80% or above.
Unique to this study setting was a preexisting sophisti-
cated electronic medical record (EMR), which integrates
data from all departments and all sites of care.
Stakeholders attributed screening increases in part to
implementation of clinical decision support in the EMR,
which allowed notification in the chart of patients who
appeared overdue for screening, and enabled distribution
of FIT kits from different points of clinical care. While
outreach efforts from clinic support staff (through
reminder letters) were already underway prior to the
implementation, the addition of the centralized auto-
mated telephone outreach program enabled multi-
modal communication with, and reminding of, patients,
which has been shown to enhance screening rates in prior
studies [38-44]. Yet, participants also reported a continued
need to refine the integration of the program with the
system, both for outreach and for ensuring completion
of stool tests.
Participants stated that changing from guaiac fecal oc-
cult blood test cards to the FIT test, a single-sample
fecal immunochemical test with implementation of a
centralized outreach program, provided much-needed
clarity about organizational priorities. Prior to imple-
mentation, administrators expressed that it was difficult
to know which screening test to prioritize for promotion
across the system. U.S. guidelines do not strongly
recommend one test over another [5,6]. Even with
improved screening rates, stakeholders in different
departments expressed continued ambivalence and
Table 4 Lessons learned: implementation challenges (n = 55)






Sample of illustrative quotes (stakeholder group
identified)
Use of automated telephone outreach
Inadequate consideration of how the reminder program
would interface with Medicare and Medicaid
reimbursement regulations
✓ “I can’t overstate the importance of communication with
External Affairs… in particular regarding Medicare
guidelines about who is eligible for screening, and how
reimbursement happened. So that was yet another whole
layer of, okay, how do you [deal with] this so that the
organization is in compliance with the federal regulation
but isn’t burdening, you know, a thousand primary care
clinicians. It… took a lot of work to get through that
issue”. —HP manager
IT department not involved early enough in program
development to determine how automatic calling system
would interface with EMR
✓ “You need an analyst who can not just supply the data
you ask for, but make sure that you’re asking for the right
data, and [that the data] are really going to meet your
needs… I think they need to be integrally involved in the
planning process. As well, you need an implementation
person… [who] can maintain a picture of what’s going
on… because you don’t want the project to become
siloized, with everybody just working independently”. —
HP manager
Organization not prepared or staffed to meet the need
for entering orders for patients who got fecal tests
mailed after the reminder call
✓ “The analyst would put it into an Excel spreadsheet and
then send a packet to our medical assistant, who would
put in all those orders. Which could be, you know, eight
hundred, twelve hundred orders. It’s a lot of ordering.
However, recently, we have gotten a system in place that
allows for batch ordering”. —HP manager
Slow response in mailing out fecal test to those patients
saying “yes” during the call negatively affected patient
compliance and interest once kits arrived at patient’s
home
✓ “It would take sometimes up to six weeks to get these
mailed out, because we couldn’t mail them out without
an order, because the lab can’t do anything with a kit that
comes back that doesn’t have an order”. —HP leader
Lack of integration or documentation of reminder calls in
the EMR increased providers’ chance of not knowing a
patient had been called
✓ ✓ ✓ The big deal [was] the complaints about not knowing
which patients were called. And that’s just something that
we can’t give them. But I think that that’s what leadership
hears the most of”. —HP leader
Use of fecal immunochemical tests
Need to improve clarity of instructions for fecal tests ✓ “I’ve had a number of patients tell me that the lab has said,
don’t mail it back [fecal test]. You need to drop it back in. So
I’m not sure if that’s an area that the organization has looked
at… I’m not sure if our mailing package might need to
change, or our instructions with the kit… But that would be
one barrier to maybe getting it back if people have been
told, either correctly or incorrectly, that they have to drop it
off in person”. —PCP
No clear process for labeling kits, both when distributed
centrally or when distributed from the point of care
✓ “We had some problems with FIT tests coming back
unlabeled. I don’t think it was a lot, but it was
enough”. —HP manager
System does not involve automatically sending fecal test
kits in the mail to every person who is due following
receipt of the automated reminder call
✓ “There are ways we can improve. I mean, we’re constantly
kind of assessing… Southern Cal [Kaiser]… automatically
sends the kit in the mail to every single person that’s
due”. —HP manager
Communication about organizational screening approach
Lack of effective and efficient ways to clearly
communicate the organization’s CRC screening approach
preferences to providers (PCPs/health teams/specialists)
✓ ✓ “The challenge is always going to be making sure your
physicians are excited about these kinds of screenings;
not just for cancer, but for a variety of different things,
and that they’re your best advocates… We need more
of a unified voice behind our preferred screening
modality”. —HP leader
Need for ways to effectively communicate and educate
resource stewardship and evidence based outcomes to
providers as they pertain to CRC screening
✓ ✓ “If the patient wants a colonoscopy, that’s a very difficult
discussion… because, if we’re still in the mode where we
do what the patient wants, then we’re going to try to do
[it] within a reasonable guideline. I don’t know how you
remedy those two issues”. —GI specialist
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Table 4 Lessons learned: implementation challenges (n = 55) (Continued)
Ongoing challenge of shifting the beliefs/habits of some
providers (PCP and specialists) away from colonoscopy as
the only appropriate screening choice for average-risk
patients
✓ ✓ ✓ “I think it’s kind of a dilemma… If a friend of mine walks
up and says, what test do you recommend to me? I
would tell them colonoscopy… I think the colonoscopy is
the best test”. —General surgeon
Need to clarify roles, processes, and expectations
between PCP and specialist regarding CRC screening
follow-up issues
✓ “One challenge that is sometimes unclear is who’s going
to follow the referral [surveillance colonoscopy after a
positive initial screening colonoscopy]. Do specialists
automatically send follow-up to the patient that you need
another one because this is positive [showed polyps], or
are they expecting us [the PCP] to automatically re-refer
them?” —PCP
Need for improvement in creating a service that
integrates all components of the program, involving
input and efforts of GI, surgery, oncology, and primary
care
✓ “It’s an upgraded service program in the sense that you
can’t do this without having oncology, surgery, GI and
primary care [work] as an integrated team. I mean, the
patient flow issue is related to both the screening
program and the subsequent care. It’s not just one little
cross sectional piece of care. It’s one piece of the
integrated process”. —GI specialist
Concerns about screening duplication
Patients new to the organization and with a recent
negative colonoscopy being inappropriately given FIT kit
✓ ✓ “We’ve seen any number of patients that come through
with a positive FIT test who have actually had a negative
colonoscopy within ten years. In my view… no one
should be allowed to order another screening test [for
them]”. —GI specialist
Lack of clarity on protocols and communication strategies
by PCPs for patients with a negative FIT who also
requested a screening colonoscopy
✓ ✓ “A lot of people have been told by their primary care that
if their FIT was negative they can’t get a colonoscopy. …
They can. You just have to have it referred. There’s a
several month waiting period. There are lots of messages
sent to primary care about this”. —General surgeon
Approach of offering multiple screening methods and
utilizing multiple outreach strategies of reminder calls
and in-clinic prompting may be creating some screening
duplication
✓ ✓ ✓ “Sometimes people get these stool cards at the Flu Clinic
or by mail when they’ve already had a colonoscopy, or
some other way they really shouldn’t have gotten one.
And then they’ll bring them back and it’s positive”. —PCP
Need to standardize documentation in EMR of patients’
prior CRC screening and related result so there is clear
and easy access to information for all providers
✓ ✓ “Sometimes it’s difficult using [EMR] what type of
screening has previously been done. I’ve had referrals
sent to me where someone gets referred for a
colonoscopy and they had one three years ago…
So far we don’t have a system-wide way to write it in
the problem list. We’re trying to standardize that. And
finding the notes when you’re just scanning the charts
is very, very difficult… even if a physician is trying to
really find that, it’s hard”. —GI specialist
Ongoing need for education
More patient education about CRC screening that can be
delivered by support staff (MAs and RNs)
✓ ✓ “Some patient education materials would be nice…
anything that would summarize the pros and the cons of
the different types of screening. And it wouldn’t be a bad
idea for some of that material to be handed to the
patients by support staff, so that while they’re waiting in
the room they could look it over and then maybe be a
little bit informed before the office visit”. —PCP
Create more consistent, uniform, centralized messages
utilizing a variety of methods (e.g., visual aids for patient
navigation, provider decision-trees, etc.)
✓ ✓ “What might be helpful is if I had a FAQ sheet [for PCP]
like what is the incidence of colon cancer for average risk
patients, fifty to sixty, sixty to seventy, etc. What is the risk
if there is a family history? And possibly a fact sheet for
patients too, because it is definitely the patients who
leave here who are undecided and they struggle or they
have questions”. —PCP
Direct patients with a recent normal colonoscopy not to
get a fecal test (FIT)
✓ “There [needs] to be a big bullet on the FIT test that says, if
you had a normal colonoscopy within the last five years,
throw this away immediately. These are automatically mailed
out to patients who the year previously had a normal
colonoscopy. Five to eight percent are positive, then they’re
wanting another colonoscopy”. —General surgeon
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Table 4 Lessons learned: implementation challenges (n = 55) (Continued)
Proactively educate patients about choices and
controversies related to screening
✓ “Anything that can be done to provide the patient with
information about the controversy or choices, or how to
pick up or get a test done… You take your FIT test and it
is positive, this is what will subsequently [occur] in your
care. So the patients sort of know where they’re going to
go with this, what the expectations are, and what Kaiser
will provide to them”. —General surgeon
Increase staff and colonoscopy resources/access
Increased sensitivity and compliance of FIT.
unintentionally created resource and access issues again
with colonoscopy
✓ ✓ “Because we’re screening more people, we’re finding
more positive FITs and it’s driving our colonoscopy rates
up. But they’re driven up appropriately… but this will
require us to, again, strategize about what we’re going to
do as an organization”. —HP leader
Continuing need for additional highly trained staff (including
mid-level providers) to do screening colonoscopies, helping
to improve wait-times and access
✓ ✓ “We’re going to need more people capable of doing a
good colonoscopy. We’ve been at the forefront in the
past of hiring PAs and training them to do that. And right
now there some considerations to do it, but that’s a big
political thing”. —HP leader
Need to make CRC screening a self-referral program,
similar to other screening programs (e.g., breast cancer
screening)
✓ “Make it self-referral”. —General surgeon
Check symbol indicates theme brought up by more than half the stakeholder group.
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different options available to patients for colorectal
cancer screening (e.g., fecal tests and endoscopy).
Some specialists and PCPs wanted to make screening
colonoscopy more readily available to interested patients
(e.g., through self-referral). Communication with program
champions in the system helped resolve some of these dis-
agreements, and has been described as a key facilitator of
CRC program implementation [35,45]. Ongoing discussions
about the changing landscape of CRC screening evidence
and best practices will likely continue to be important in
the coming years with the completion of large trials com-
paring FIT to colonoscopy [46,47].
An unintended consequence of program implemen-
tation was more screening duplication. Stakeholders
reported that the ease of access and ubiquitous distri-
bution of FIT led to some waste of fecal test kits and
also to some over-screening. This finding is a down-
side to the benefit of achieving high screening rates by
using multimodal reminders. PCPs and health plan
managers reported that some patients received several
kits at different points of care, because of electronic
alerts indicating that he/she was overdue for screen-
ing. Those with low screening adherence would some-
times lose kits or would keep more than one at home,
incomplete. Prior studies have targeted non-adherent
patients by employing tailored navigation through
telephone outreach by a nurse or medical assistant,
though success of this approach has been variable, and
widespread implementation would need to consider cost-
benefit tradeoffs [48,49]. Screening overuse stemmed from
patients who were willing to screen whenever prompted,
sometimes completing more than one kit per year, orcompleting a colonoscopy less than 10 years after a
prior negative colonoscopy. Stakeholders reported that
incomplete documentation in the EMR of prior colon-
oscopy outside the health plan contributed to over-
screening of this nature, which has been a previously
reported challenge in other systems [50]. In theory,
additional clinical alerts [45,50-54] at the point of or-
dering a fecal test kit would address both the duplica-
tion in fecal test kits and inadequate documentation of
prior colonoscopy. However, computer-alert “fatigue”
should be a consideration in implementing additional
electronic prompting and oversight. Previous research
has shown that complex clinical decision support
initiatives to support CRC screening can result in a
subsequent decline in quality outcomes due to this
phenomenon [55].
Lastly, in spite of the focus of the program being fecal
tests, stakeholders at all levels discussed the ongoing
need to expand colonoscopy resources, namely, increasing
the number of endoscopists and the dedicated facilities and
staff for offering this procedure. Both administrators and
specialists had concerns about limitations in colonoscopy
resources, and how the organization should manage these
resources while still offering screening to all eligible pa-
tients. Resource constraints are likely to remain an ongoing
concern in colorectal cancer screening programs [56,57].
Limitations and strengths
Our study could not discern whether stakeholders’ re-
sponses represent the feelings of non-interviewed clini-
cians, specialists, and health plan managers across the
Kaiser Permanente system. However, responses were suf-
ficiently consistent that we could identify themes and
Table 5 Reported facilitators and barriers to program implementation, by PRISM domains
Core PRISM domains Facilitators Barriers
Program (intervention)
domain
• Centralized screening outreach addressed primary care
time constraints in offering screening
• Optimal choice of screening test (i.e., fecal testing or
endoscopy) was unclear from evidence
• Adoption of FIT gave providers a fecal test method that
they could more easily explain, addressing primary care time
constraints
• Information technology department was not involved
early enough in the process to determine best interfaces
with EMR
• Improved accuracy of FIT enabled communication of more
unified message about screening prioritization within the
organization
• Slow response in mailing out fecal tests to those that
accepted outreach impacted the efficiency of the program
• Incorporating automated screening reminder alert into
electronic medical record built upon existing “care gap”
reminder structure
• Increased compliance with new FIT kit unintentionally
created access challenges with colonoscopy services for a
while
• Incorporating automated screening reminder alert




• There was interest in increasing quality performance
numbers (e.g., HEDIS measures) to the levels of those of
other comparable health care organizations
• Alignment of automated reminders and fecal test orders





• Dedicated team for implementation had prior experience
in implementing automated reminder programs for other
health screening services
• There was a need to improve integration of program
(e.g., documentation of centrally mailed FIT) within EMR
• Data showing increased screening rates supported
effectiveness of program
• There was a need to improve staffing levels and training for
ordering/mailing FIT kits centrally, and tracking diagnostic
follow ups
• Recent emphasis on increasing capacity for colonoscopy
enabled program to absorb increased number of
colonoscopies
• There was a need to improve workflows and EMR
documentation to decrease screening duplication errors
• Cross-department support and coordination between
population care leaders, information technology, laboratory
services, GI department, PCPs and support staff enabled
maintenance and improvement of program
• There was a need to improve FIT kit instructions and
labeling of FIT kits to decrease errors in test completion
and processing
Recipients domain • Strong leader, manager, clinician, specialist and frontline
staff belief in the importance of CRC screening facilitated
program acceptance
• There was an ongoing need to continue education and to
shift habits of some providers/specialists away from
colonoscopy as the only screening choice
• An historical cultural emphasis on screening helped the
intervention to be perceived as an effective and important
strategy worthy of continuing
• There was an ongoing need to clarify roles, processes and
expectations between providers and specialists regarding
positive screening follow-up issues
• Providers and staff felt more trained on and educated
about CRC screening options and resource stewardship
issues
• There was a continued need to provide performance data
feedback and clear expectations regarding CRC screening
rates and organizational preferences to all staff
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may be that the lessons learned in this system, which
has internal practice guidelines and a sophisticated
electronic medical record, may be difficult to apply in
systems lacking those attributes. However, ~80 million
people in the U.S. receive care from an HMO, which
likely have similar organizational attributes as those
described here. Two strengths of this qualitative study
are that we obtained a variety of viewpoints through
multiple interviews, and that we elicited responses at a
variety of time points relative to the quality interven-
tions. We also used a prespecified interview guide, a
trained interviewer, and a repeated, iterative process of
reliability-checking among members of the research
team.Conclusions
Our analyses of multiple stakeholder viewpoints about
quality-improvement efforts to raise CRC screening
rates yielded valuable information about successes,
and remaining challenges, to successful implementa-
tion of a reminder program in a highly integrated U.S.
managed health care system. CRC screening rates im-
proved 10% during program implementation and con-
tinue to rise. The implementation program capitalized
on historical facilitators (an integrated health system
with internal guidelines and a sophisticated electronic
medical record), while also removing some historical
barriers to screening (organizational resource, staff,
and time burden; patient non-compliance). Success
was due in large part to the activation of three different
Liles et al. Implementation Science  (2015) 10:41 Page 15 of 16domains within the PRISM framework: changing the deliv-
ery system design through centralizing screening efforts
(implementation infrastructure); switching to a more
accurate and feasible fecal test (external environment);
and providing educational and electronic support
(recipients of intervention). The combination of these
actions resulted in a successful and sustained improve-
ment in CRC screening rates.
Health plan leaders, PCPs, specialists, and support
staff in other health systems can use our results to ad-
dress remaining barriers to raising CRC screening rates.
All the stakeholders we interviewed acknowledged the
complexity of understanding and applying the scientific
evidence for CRC screening, and expressed a need for
ongoing education of both providers and patients about
organizational emphases on CRC screening. They also
wanted to understand, and have input into, the scientific
reasoning informing an organization’s choices in recom-
mending one test over others for people at average risk
of colon cancer. Further refinement of the stool test
distribution system should focus on reducing duplication
of test dissemination, and installing new procedures for
identifying and documenting prior endoscopies done
outside of the system. Perhaps the greatest challenge to
the system we studied is that increases in FIT testing,
and the greater sensitivity of FIT, have led to greater de-
mand for colonoscopies. Ultimately, decision-makers
will need to re-examine the relative benefits of joint in-
formed decision-making (specifically regarding patient
choice of screening test) and weigh them against the
benefits of centralized screening efforts through a single
test (e.g., fecal immunochemical testing), and concen-
trate their resources accordingly.
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